baber/WOPTO huggingface dataset:
Patent NZ-572887-A (NZ)
Title: A dry powder inhaler comprising an inhaler body and a cartridge movably mounted in the opening in the body
Inventor: VILLAX PETER
IPC: A61M15/00
Filed: 2007-05-11
Abstract: A dry powder inhaler for pulmonary or nasal use comprising at least an inhaler body (100) and a cartridge with one or two compartments (121) each containing one dose of a drug is disclosed. The compartment (121) has separate holes to admit air and to deliver powder (122), which, in use, communicate with an inhalation channel (103) in the inhaler body (100). To prevent the powder (122) from leaking through the compartment holes before use, the air admission holes are of reduced dimension, thereby blocking or hindering the powder (122) to exit under the force of gravity. When the cartridge is inserted inside the inhaler body (100), all its holes are blocked. By sliding the cartridge in relation to the body (100) until the inhalation position is reached, the holes come into fluid communication with one another and with the inhalation channel (103). This allows a flow of air to disperse and entrain the dose through the mouthpiece. Several embodiments of the inhaler are disclosed.
Patent NZ-578695-A (NZ)
Title: A foodstuff comprising more than one more layer of fruit wrapped around the meat
Inventor: LYNCH CARL DANIEL
IPC: A23L1/00
Filed: 2009-07-29
Abstract: A foodstuff 1 comprising meat and fruit 2 3, the meat and fruit 2 3 combined to provide a taste which is different to the taste of either one of these, the foodstuff 1 being in the form of a unitary item and characterised in that the fruit 2 3 has been layered around the meat.
Patent NZ-585936-A (NZ)
Title: Electronic detection tag having an abradable layer
Inventor: FOLKERS CHRISTIANUS JOHANNES
IPC: A01K29/00
Filed: 2011-06-03
Abstract: A detection tag for the detection of the reproductive status of animals and a method for detecting reproductive status of animals are disclosed. The detection tag (201) has electronic components (203) such as an integrated circuit and is capable of electronically transmitting a signal. The detection tag has a body with a first surface that is affixable to the hide of an animal and a second and opposite surface which includes abradable material (401). The detection tag is configured such that removal of some or all of the abradable material alters the ability of the detection tag to transmit a signal electronically or alters a characteristic of the electronically transmitted signal. The abradable material can be a removable flood coat layer, and removal of some or all of the flood coat layer of the second surface of the detection tag allows or disallows the electronic transmission of status information from the detection tag. The abradable material can include a conductive circuit and the detection tag is configured such that partial or complete removal of the conductive circuit, or breaking of the conductive circuit, allows the electronic transmission of status information from the detection tag
Patent NZ-588020-A (NZ)
Title: Security system including controller, remote detectors and spraying devices
Inventor: HART NIGEL
IPC: G08B15/02
Filed: 2009-03-11
Abstract: A security system comprising: a controller (12); and a plurality of dispensing devices (16A, 16B). The controller is configured to receive signals from a plurality of remote detectors (14A, 14B) and transmit signals to the plurality of dispensing devices. The controller is adapted to determine which of the plurality of detectors has transmitted a signal and transmit a signal to a selected one or more dispensing devices to dispense a fluid based on that determination. Each dispensing device is configured to receive signals from the controller and dispense fluid when a signal is received.
Patent NZ-591412-A (NZ)
Title: Modification of plant flavonoid metabolism (2)
Inventor: MOURADOV AIDYN
IPC: A01H1/00
Filed: 2008-06-25
Abstract: NZ 591412 Disclosed is a substantially purified or isolated nucleic acid or nucleic acid fragment encoding a MYC protein, or complementary or antisense to a sequence encoding a MYC protein, said nucleic acid or nucleic acid fragment including a nucleotide sequence as defined in the complete specification. Also disclosed is a method of modifying: flavonoid biosynthesis in a plant; protein binding, metal chelation, anti-oxidation, and/or UV-light absorption in a plant; pigment production in a plant; plant defence to a biotic stress; and forage quality of a plant by disrupting protein foam and/or conferring protection from rumen pasture bloat. The method includes introducing the specific nucleic acid into a plant.
Patent NZ-592697-A (NZ)
Title: System for preparing packages of sliced food which uses spray to minimise bacterial contamination
Inventor: RAMABADRAN ARUN
IPC: A23B4/18
Filed: 2009-04-30
Abstract: 592697 Disclosed is a system for preparing packages of sliced food product which minimises bacterial contamination and outgrowth within the packaged food product. The system includes a powered slicer to sequentially separate slices of food product to create a stack of food product slices. The system also includes a first spray nozzle (34a) for depositing a first predetermined amount of the antimicrobial preparation onto the first face (36) of the food log (1) or other food product piece each time a slice is removed as well as a second spray nozzle (34c) for depositing a second predetermined amount of the antimicrobial preparation into a vacuum pouch prior (37) to reception of a stack (38) within the pouch.
Patent NZ-593266-A (NZ)
Title: Hypoallergenic dermatological composition comprising extract from cereal plants
Inventor: MANDEAU ANNE
IPC: A61K8/97
Filed: 2009-09-15
Abstract: Patent No. 593266 Disclosed is the use of an extract of aerial part(s) of cereal or pseudocereal harvested before ear emergence, excluding the grains, in the preparation of a composition for the prevention of allergies to cereal grain proteins, in a subject.
Patent NZ-595361-A (NZ)
Title: Chimeric factor h binding proteins (fhbp) and methods of use
Inventor: BEERNINK PETER
IPC: A61K39/00
Filed: 2010-04-29
Abstract: Patent No. 595361 Disclosed is a non-naturally occurring fHbp, comprising, from N-terminus to C-terminus: VA-I3-VB-I4-VC-I5-VD-I6-VE, wherein the combination of alleles for each of VA, VB, VC, VD, and VE variable segments is not found in Table 7, wherein each of the variable segments is either alpha (a) progenitor sequence or a beta (b) progenitor sequence such as VAADIGAGLADALTAPLDHKDKSLQSLTLDQSVRKNEKLKLAAQGAEKTYGNGDSLNTGKLKNDKVSRDFDIRQLEVDGQLITLESGEFQVYKQSHSALTALQTEQVQDSEDSGKMVAKRQFRIGDIAGEHTSFDKLPKGGSATYRGTAFGSDDAGGKLTYTIDFAAKQGHGKIEHLKSPELNVDLAAAYIKPDEKHH AVISGSVLYNQAEKGSYSLGIFGGKAQEVAGSAEVKTVNGIRHIGLAA.
Patent NZ-597676-A (NZ)
Title: Crystalline anti-hTNFalpha antibodies
Inventor: BORHANI DAVID W
IPC: C07K1/00
Filed: 2007-10-25
Abstract: NZ 597676 Disclosed is the use of an effective amount of a crystal of an isolated human anti-hTNFalpha antibody in the manufacture of a medicament for the treatment of a TNFalpha-related disorder. The disclosed crystal of an isolated human anti-hTNFalpha antibody is prepared from an isolated human antibody with a light chain variable region (LCVR) comprising the amino acid sequence of SEQ ID NO: 1, as defined in the specification, and a heavy chain variable region (HCVR) comprising the amino acid sequence of SEQ ID NO: 2, as defined in the specification; wherein the crystal has a length of about 2-500?m and an l/d ratio of about 3 to 30.
Patent NZ-599719-A (NZ)
Title: Closed-loop hydraulic apparatus for converting wave energy
Inventor: LAXTON NIGEL
IPC: F03B13/14
Filed: 2010-11-15
Abstract: 589979 A dental fluid delivery system for use with a dental drill is disclosed. The delivery system comprises a coolant water supply unit (51), a drive air line (52), a water line (53) and a coolant mist air controller (80). The coolant water supply unit (51) includes a controller (10) and a water container (11), the water controller (10) having a drive air inlet (43), a water inlet communicatively connected to the water container, a drive air outlet (46) and a water outlet (31). A first bore within the controller (10) permits passage of drive air from the air inlet (43) to the air outlet (46) and is controller with a knob (55). A second bore extending from the first bore permits drive air into the water container (11). A third bore extending from the water container (11) permits passage of liquid from the container (11) to the water outlet (31), and fourth and fifth bores separated by a flexible membrane selectively controls communication between the fourth bore and an exhaust vent. The drive air line (52) is connected to the drive air outlet (46) of the water supply unit (51) and the water line (53) is connected to the water outlet (31) of the water supply unit (51). The coolant mist air controller (80) connects to a dental drill (50), the mist air controller (80) having a drive air inlet (99), a drive air outlet, a water inlet (84), a water outlet, and a mist air outlet.
Patent NZ-600994-A (NZ)
Title: Darunavir polymorph and process for preparation thereof
Inventor: PHULL MANJINDER SINGH
IPC: C07D493/04
Filed: 2010-10-06
Abstract: 600994 There is disclosed crystalline darunavir hydrate free of any non-aqueous solvent. Also disclosed is a process for preparing darunavir hydrate according to any one of claims 1 to 6comprising reacting 1-([[(3R,3aS,6aR)hexahydrofuro[2,3-b]furan-3-yloxy]carbonyl]oxy)-2,5-pyrrolidinedione with 4-amino-N-(3-amino-2-hydroxy-4-phenylbutyl)-N-isobutylbenzenesulfonamide to obtain a residue; stirring the residue in a mixture of water miscible solvent and water and drying the solid to obtain crystalline darunavir hydrate, a process for preparing darunavir hydrate comprising stirring darunavir, having at least one non-aqueous solvent in the crystal lattice, in a mixture of water miscible solvent and water; then filtering the mixture to obtain a solid then stirring the solid in water; filtering the solid/water mixture and drying to obtain crystalline darunavir hydrate, along with its use in treatment of HIV and in the manufacture of amorphous darunavir.
Patent NZ-601157-A (NZ)
Title: Data storage system and method for calibrating same
Inventor: MAHNAD FARAMARZ
IPC: G11B7/24082
Filed: 2010-12-07
Abstract: A method of calibrating a data storage system and the data storage system are disclosed. The Data storage system comprises an optical media; an optical pick-up unit and at least one controller. The optical media has a defect and a plurality of tracks on each side of the defect exhibiting (i) fields of modulated wobble indicative of defect location information next to the defect and (ii) fields of modulated wobble indicative of data. The optical pick-up unit is configured to read the fields of modulated wobble. At least one controller is operatively arranged with the pick-up unit and is configured to, in response to the pick-up unit detecting defect location information on one side of the defect, (i) command movement of the media in a first direction such that the pick-up unit is positioned adjacent to the fields of modulated wobble indicative of data on the other side of the defect, (ii) command the pickup unit to refocus on the fields of modulated wobble indicative of data on the other side of the defect, and (iii) after refocusing, command movement of the media in a second direction opposite the first such that the defect approaches the pick-up unit.
Patent NZ-604835-A (NZ)
Title: Pyridin- 2 - yl sulfanyl acid esters and process for the preparation thereof
Inventor: BALWANI SAKSHI
IPC: C07D213/70
Filed: 2011-07-20
Abstract: 604835 Disclosed herein is a compound of formula 1, wherein the compound is 3-(2-pyridylthio) propionic acid butyl ester, 3-(2-pyridylthio) propionic acid pentyl ester, and 7-(2-pyridylthio) heptanolc acid ethyl ester; or wherein R1 is H, R2 is COOMe, R3 is (CH2)nCOOR4, R4 is C2H5,C3H7, C4H9, C5H11, C6H11 and n is 1–7. Additionally disclosed is a process for preparing a compound of formula 1 comprising irradiating Barton ester with sun light; and the compound for inhibiting ICAM-1 (intercellular cell adhesion molecule-1) expression.
Patent NZ-610871-A (NZ)
Title: An aerosol generating system with prevention of condensate leakage
Inventor: THORENS MICHEL
IPC: A24F40/485
Filed: 2011-12-02
Abstract: An aerosol generating system 103 for heating a liquid aerosol-forming substrate, comprises an aerosol-forming chamber 127, and leakage prevention means configured to prevent or reduce leakage of liquid aerosol condensate from the aerosol generating system. The leakage prevention means comprises at least one cavity 305, 307 in a wall of the aerosol-forming chamber 127, for collecting liquid condensate formed from the aerosol-forming substrate and the cavity has a cross-sectional dimension x, where x is between 0.5 mm and 1 mm.
Patent NZ-614142-A (NZ)
Title: Aerated fiber cement building products and methods of making the same
Inventor: MUELLER THOMAS PATRICK
IPC: C04B111/40
Filed: 2012-04-27
Abstract: The disclosure relates to a fiber cement formulation, comprising: a cementitious hydraulic binder; cellulose fibers; and an air entrainment agent, said air entrainment agent comprises 0.1%-2% by weight, wherein the air entrainment agent is selected from the group consisting of salts of wood resin, synthetic detergents, salts of sulfonated lignin, salts of petroleum acids, salts of proteinaceous material, fatty and resinous acids and salts thereof, alkylbenzene sulfonates, salts of sulfonated hydrocarbons, wood resins, sulfonated hydrocarbons, and combinations thereof and/or the air entrainment agent comprises vinsol resin or a sacrificial filler. The disclosure also relates to a building article comprising multiple overlaying fiber cement substrate layers bonded to each other to form a fiber cement matrix, also having small and uniform entrained air pockets distributed throughout. The fiber cement substrate layers may comprise cellulose fibers. The disclosure also refers to a method of entraining air in a fiber cement panel.
Patent NZ-617759-A (NZ)
Title: Methods and apparatuses for altering measurement time and bandwidth during a measurement
Inventor: KAZMI MUHAMMAD
IPC: H04W64/00
Filed: 2012-03-29
Abstract: Disclosed are user equipment (101) and corresponding methods for handling a cell change from a first cell to a second cell in a wireless communications network. The user equipment alters a duration of a measurement time over which at least one measurement is performed, and alters a measurement bandwidth of the at least one measurement. The alterations may be performed based on associated bandwidths of the first and second cells. The network node (103, 113, 115) can also sends a notification of a cell change and information associated with the cell change to the user equipment. The network node receiving measurement data of at least one measurement performed over an altered measurement bandwidth and an altered duration of measurement time. The alterations are based on the information associated with the cell change.
Patent NZ-617966-A (NZ)
Title: Non-invasive, wireless, portable device applicable to the finger to reduce the risk of sudden infant death syndrome and reduce the risk of apnea, slower heart rate, and heart arrest in all age groups
Inventor: DIEGO ALEJANDRO DELIA
IPC: A61N1/38
Filed: 2013-11-19
Abstract: Disclosed is a non-invasive, portable device applicable to the finger or toe in order to reduce the risk of sudden infant death syndrome and the risk of apnoea, slower heart rate, and heart arrest in all age groups. The device is comprised of: a) a sensor section (1) including a blood oxygen saturation sensor delivering a blood oxygen saturation measurement signal and a heart rate sensor delivering a heart rate measurement signal; b) a power supply section (9); c) a control and alarm-generating circuit (7), d) a pair of metal electrodes (6); and e) an electric stimulation generator (10). The control and alarm-generating circuit (7) is designed to receive the blood oxygen saturation measurement signal, compare it with a blood oxygen saturation threshold value predefined by the user and generate a stimulation signal if the blood oxygen saturation signal falls below the blood oxygen saturation threshold. The control and alarm-generating circuit (7) is designed to also receive the heart rate measurement signal, compare it with a heart rate threshold value predefined by the user and generate the stimulation signal if the heart rate signal falls below the heart rate threshold. The electric stimulation generator (10) is designed to receive the stimulation signal from the control and alarm measurement circuit (7) and to generate an electric signal applied to the pair of electrodes (6) to apply a stimulus to the user when the blood oxygen saturation falls below the threshold. The electrodes (6) are located on the sides of the blood oxygen saturation sensor. All elements a) - e) are contained in the same housing and do not require wiring to external elements.
Patent NZ-716313-A (NZ)
Title: Detection and monitoring of resistance to an imidazothiazole anti-helminthic in nematodes
Inventor: PRICHARD ROGER
IPC: C12Q1/68
Filed: 2014-07-11
Abstract: The present disclosure concerns the determination of the resistance or the susceptibility of a nematode from a Haemonchus genus to an imidazothiazole anti-helmintic based on the assessment of the presence of an indel in the Hco-acr-8 gene (or the Hco-acr-8 gene gene ortholog). The present disclosure also provides tools and commercial packages for making such assessment.
Patent NZ-719122-A (NZ)
Title: Processes for making compounds useful as inhibitors of atr kinase
Inventor: DURRANT STEVEN JOHN
IPC: C07D413/04
Filed: 2012-09-28
Abstract: The present disclosure relates to processes and intermediates for preparing compounds useful as inhibitors of ATR kinase, such as aminopyrazine-isoxazole derivatives and related molecules. The present disclosure also relates to compounds useful as inhibitors of ATR protein kinase. The disclosure relates to pharmaceutically acceptable compositions comprising the compounds; methods of treating of various diseases, disorders, and conditions using the compounds; processes for preparing the compounds; intermediates for the preparation of the compounds; and solid forms of the compounds. The compounds have formula (I) or (II) wherein the variables are as defined herein.
Patent NZ-730724-A (NZ)
Title: Novel methyl-piperidine compounds useful for inhibiting microsomal prostaglandin e2 synthase-1
Inventor: FISHER MATTHEW JOSEPH
IPC: A61K31/4709
Filed: 2015-10-22
Abstract: The present invention provides compounds of Formula (1), or a pharmaceutically acceptable salt thereof, formula (1), where R, R1, and G are as described herein; methods of preparing the compounds; and use of the compounds to treat pain and/or inflammation associated with arthritis or osteoarthritis.
Patent NZ-740229-A (NZ)
Title: Patient interface with foam seal-forming structure
Inventor: SCHEINER RUPERT
IPC: A61M16/06
Filed: 2016-09-23
Abstract: A cushion assembly for a patient interface for sealed delivery of a flow of air at a continuously positive pressure with respect to ambient air pressure to an entrance to a patient’s airways including at least entrance of a patient’s nares, wherein the patient interface is configured to maintain a therapy pressure in a range of about 4 cmH20 to about 30 cmH20 above ambient air pressure in use, throughout the patient’s respiratory cycle, while the patient is sleeping, to ameliorate sleep disordered breathing, the cushion assembly comprising: a foam cushion configured to seal against the patient’s face; and an elastomeric support portion configured to support the foam cushion and form at least part of a chamber together with the foam cushion, the elastomeric support portion comprising: a main body that forms a continuous perimeter around the chamber; and a resiliently flexible lip that forms a pivotable seat for the foam cushion and extends from the main body toward an interior of the chamber, an outer perimeter of the lip being anchored to the main body so that the outer perimeter of the lip is fixed relative to the main body while an inner perimeter of the lip is movable relative to the main body, wherein the lip further comprises a reinforced section with a supplemental support that anchors a span of the lip to the main body, the reinforced section of the lip being located at a region of the cushion assembly that is configured to be laterally adjacent to the patient’s nasal ridge when the cushion assembly is mounted on the patient’s face.
Patent NZ-744397-A (NZ)
Title: Blacklip abalone (haliotis rubra) extract
Inventor: OSBORNE SIMONE
IPC: A61K35/618
Filed: 2017-01-20
Abstract: The present invention provides extracts and extract fractions of blacklip abalone (Haliotis rubra) processing waste. The extract or extract fractions comprise biologically active components, such as proteins, and anionic polysaccharides, that may be selected from anti-thrombotic agents and anti-inflammatory agents. Processes for the preparation of the extract and fractions thereof are described. The preparation process comprises enzymatic digestion, centrifugation, filtration, and desalting steps. Use of the extract or fraction as an ingredient, medicament for IL-6 mediated diseases such as arthritis, inflammatory or thrombotic diseases, dietary supplement or nutraceutical is also described.
Patent NZ-748016-A (NZ)
Title: Use of cannabidiolic acid in the treatment of autism spectrum disorder and associated disorders
Inventor: GUY GEOFFREY
IPC: A61K45/06
Filed: 2017-04-11
Abstract: The present invention relates to the use of cannabidiolic acid (CBDA) in the treatment of autism spectrum disorder (ASD) and ASD-associated disorders, such as Fragile X syndrome (FXS); Rett syndrome (RS); or Angelman syndrome (AS). CBDA has been shown to be particularly effective in improving cognitive dysfunction in rodent models of ASD, FXS, RS and AS. The CBDA is preferably substantially pure. It may take the form of a highly purified extract of cannabis such that the CBDA is present at greater than 95% of the total extract (w/w) and the other components of the extract are characterised. Alternatively, the CBDA is synthetically produced.
Patent NZ-758571-A (NZ)
Title: Chimeric antigen receptors based on single-domain antibodies and methods of use thereof
Inventor: FAN XIAOHU
IPC: C07K19/00
Filed: 2016-08-10
Abstract: The present application provides a chimeric antigen receptor (CAR) comprising a polypeptide comprising: (a) an extracellular antigen binding domain comprising a first single-domain antibody (sdAb) specifically binding to a first antigen and a second sdAb specifically binding to a second antigen, wherein each of the first and second sdAb is a VHH domain; (b) a transmembrane domain; and (c) an intracellular signaling domain. Further provided are nucleic acids, vectors, engineered immune effector cells, pharmaceutical compositions and uses thereof.
Patent PT-103211-A (PT)
Title: Process is for allylic oxidation of unsaturated compounds using hydro-peroxide of T-butyl and bismuth catalyst
IPC: C07C45/27
Filed: 2004-11-17
Abstract: The process is for allylic oxidation of unsaturated compounds using hydro-peroxide of T-butyl and catalyzers of bismuth.
Patent PT-109009-A (PT)
Title: Dispositivo de aquecimento
Inventor: RICARDO JORGE DE SOUSA VIEIRA
IPC: F24H1/06
Filed: 2015-12-03
Abstract: A INVENÇÃO REFERE-SE A UM DISPOSITIVO DE AQUECIMENTO COM PELO MENOS UM ACUMULADOR DEÁGUA DOMÉSTICA (12A), QUE APRESENTA PELO MENOS UMA PAREDE EXTERNA(14A).PROPÕE-SE QUE UMA FORMA DA PAREDE EXTERNA (14A) SEJA PELO MENOS PARCIALMENTE MODIFICÁVEL.